Nursing-Led CRE Screening Moves Into the ICU Bedside
In critically ill ICU patients, carbapenem-resistant Enterobacteriaceae screening does not have to wait for a distant microbiology bench. The figures from this PLOS Global Public Health study center on a laboratory-independent bedside protocol, with rectal swab screening used to detect gastrointestinal carriage and compare performance against standard centralized culture.
The cohort included N = 220 critically ill ICU patients. Rectal swabs served as the anchor specimen for carriage detection, a practical choice in a population where colonization status can shape infection-control decisions long before invasive infection emerges. In this setting, the clinical value of screening is immediate: identifying carriage can inform isolation precautions, transmission prevention, and antimicrobial stewardship in an environment where resistant organisms move quickly between patients, hands, and surfaces.
One sentence captures the operational shift. Frontline nursing staff carried out the bedside screening protocol.
Rectal Swabs, Colony Morphology, and a Faster Readout
The visual material shows the phenotypic expression of rectal swab cultures after 18–24 hours of incubation. Positive cultures displayed the metallic blue or indigo colony appearance characteristic of the Klebsiella, Enterobacter, Serratia and Citrobacter group, often abbreviated as KESC. In the bedside setup, target colonies grew in a small-volume localized portable incubator, and the image caption describes denser clusters and more robust colony size than those processed in a standard laboratory forced-convection unit. The proposed reason is accelerated thermal equilibrium, which is plausible in a compact incubation environment where heat transfer reaches the specimen more quickly and more uniformly.
This matters because speed in microbiology is not a cosmetic improvement. In the ICU, a faster visual readout can alter contact precautions, cohorting, environmental cleaning intensity, and the timing of communication between bedside staff and infection prevention teams. A detection pathway that starts and ends at the point of care can reduce the delay between specimen collection and action, especially when colonization status influences outbreak control rather than individual treatment alone.
The negative plates were equally informative. CRE-negative cultures showed complete inhibition of non-resistant flora, and the caption specifically notes zero environmental cross-contamination across both incubation setups. For a bedside method to be credible, containment is as important as detection. Any portable system used near the ICU has to preserve microbiologic fidelity while avoiding the kind of contamination that would make results operationally useful but clinically unreliable.
Diagnostic Performance and Procedural Safety Were Tested Together
Table 2 is framed around two questions at once: how well the bedside screening protocol performs diagnostically, and how safely frontline nursing staff can execute it relative to centralized microbiology culture. That pairing is important. A screening method in a high-acuity environment fails if it is accurate but cumbersome, or convenient but unsafe. The study design therefore links test performance with procedural safety parameters, signaling an implementation focus rather than a purely laboratory one.
The emphasis on nursing staff is particularly relevant for real-world ICU workflows. Nurses already sit at the center of specimen collection, device care, infection-control surveillance, and bedside reassessment. A laboratory-independent protocol that can be carried out by frontline clinicians has obvious deployment advantages in resource-constrained settings, where access to centralized microbiology may be delayed or uneven. It also opens a path for earlier recognition of gastrointestinal carriage without depending on transport, batching, or backlogged processing queues.
Still, bedside microbiology raises a narrow but important question: can convenience preserve the same interpretive rigor as a conventional lab workflow? The table title suggests the investigators examined this directly rather than assuming equivalence. In resistant organism surveillance, the practical threshold is not only whether a plate grows a colony, but whether the workflow can be trusted in active ICU practice. A false reassurance at the bedside is as dangerous as a missed carrier.
Why CRE Colonization Matters in Critically Ill Patients
Carriage of CRE in the gastrointestinal tract is more than a microbiology label. In critically ill patients, colonization can precede clinical infection and can also seed transmission within units where invasive devices, broad-spectrum antibiotics, and prolonged stays create ideal conditions for resistant organisms to spread. Detecting carriage early gives infection prevention teams a chance to intervene before the organism announces itself through bloodstream infection, pneumonia, or another severe nosocomial complication.
The figures also hint at the broader public health logic behind the work. A portable incubator paired with bedside screening reduces dependence on centralized infrastructure and may be especially relevant in settings where laboratory access is limited or turnaround times are too slow for infection-control decisions. The point is not to replace clinical microbiology wholesale. It is to move the first decision point closer to the patient when the epidemiology of resistance demands speed.
The morphology described in the image caption remains a classic microbiologic clue. Metallic blue or indigo colonies in the KESC group are not an abstract laboratory detail; they are the visible signal of organisms that can drive difficult ICU outbreaks. When such a phenotype can be recognized after 18–24 hours in a portable system, the workflow becomes potentially actionable within a single clinical day rather than a delayed reporting cycle.
What the Figures Support, and What They Do Not
These figures support feasibility, visible growth characteristics, and a safety-oriented comparison with standard culture. They do not, by themselves, provide the full clinical readout of the study’s diagnostic metrics, nor do they substitute for the complete methods, patient-level outcomes, or unit-level epidemiology. Even so, the core message is clear from the captions alone: CRE surveillance can be brought closer to the bedside without losing the central microbiologic features that make screening meaningful.
That has direct implications for infection prevention in ICU care, where timing of detection shapes everything from isolation logistics to transmission interruption. The remaining practical question is not whether CRE carriage matters—it does—but how reliably a bedside protocol can scale across different wards, staffing models, and microbiology workflows while maintaining the same diagnostic discipline shown in this cohort.